Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing – results from a cross-sectional study in Ethiopia

BACKGROUND: Currently, antiretroviral therapy (ART) is recommended for all HIV-positive patients with tuberculosis (TB). The timing of ART during the course of anti-TB treatment is based on CD4 cell counts. Access to CD4 cell testing is not universally available; this constitutes an obstacle for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Skogmar, Sten, Balcha, Taye T., Jemal, Zelalem H., Björk, Jonas, Deressa, Wakgari, Schön, Thomas, Björkman, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925806/
https://www.ncbi.nlm.nih.gov/pubmed/24560255
http://dx.doi.org/10.3402/gha.v7.23105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925806/
https://www.ncbi.nlm.nih.gov/pubmed/24560255
http://dx.doi.org/10.3402/gha.v7.23105

Ejemplares similares